Testing the Efficacy of a Brief, Self-Guided Mindfulness Ecological Momentary Intervention on Emotion Regulation and Self-Compassion in Social Anxiety Disorder: Randomized Controlled Trial.

Nur Hani Zainal, Hui Han Tan, Ryan Yee Shiun Hong, Michelle Gayle Newman
Author Information
  1. Nur Hani Zainal: Department of Psychology, National University of Singapore, Singapore, Singapore. ORCID
  2. Hui Han Tan: Department of Psychology, National University of Singapore, Singapore, Singapore. ORCID
  3. Ryan Yee Shiun Hong: Department of Psychology, National University of Singapore, Singapore, Singapore. ORCID
  4. Michelle Gayle Newman: Department of Psychology, The Pennsylvania State University, University Park, PA, United States. ORCID

Abstract

BACKGROUND: Theories propose that brief, mobile, self-guided mindfulness ecological momentary interventions (MEMIs) could enhance emotion regulation (ER) and self-compassion. Such changes are posited to be mechanisms of change. However, rigorous tests of these theories have not been conducted.
OBJECTIVE: In this assessor-blinded, parallel-group randomized controlled trial, we aimed to test these theories in social anxiety disorder (SAD).
METHODS: Participants with SAD (defined as having a prerandomization cut-off score ≥20 on the Social Phobia Inventory self-report) were randomized to a 14-day fully self-guided MEMI (96/191, 50.3%) or self-monitoring app (95/191, 49.7%) arm. They completed web-based self-reports of 6 clinical outcome measures at prerandomization, 15-day postintervention (administered the day after the intervention ended), and 1-month follow-up time points. ER and self-compassion were assessed at preintervention and 7-day midintervention time points. Multilevel modeling determined the efficacy of MEMI on ER and self-compassion domains from pretrial to midintervention time points. Bootstrapped parallel multilevel mediation analysis examined the mediating role of pretrial to midintervention ER and self-compassion domains on the efficacy of MEMI on 6 clinical outcomes.
RESULTS: Participants demonstrated strong compliance, with 78% (149/191) engaging in at least 80% of the MEMI and self-monitoring prompts. MEMI was more efficacious than the self-monitoring app in decreasing ER goal-directed behavior difficulties (between-group Cohen d=-0.24) and lack of emotional clarity (Cohen d=0.16) and increasing self-compassion social connectedness (Cohen d=0.19), nonidentification with emotions (Cohen d=0.16), and self-kindness (Cohen d=0.19) from pretrial to midintervention time points. The within-group effect sizes from pretrial to midintervention were larger in the MEMI arm than in the self-monitoring app arm (ER goal-directed behavior difficulties: Cohen d=-0.73 vs -0.29, lack of emotional clarity: Cohen d=-0.39 vs -0.21, self-compassion domains of social connectedness: Cohen d=0.45 vs 0.19, nonidentification with emotions: Cohen d=0.63 vs 0.48, and self-kindness: Cohen d=0.36 vs 0.10). Self-monitoring, but not MEMI, alleviated ER emotional awareness issues (between-group Cohen d=0.11 and within-group: Cohen d=-0.29 vs -0.13) and reduced self-compassion acknowledging shared human struggles (between-group Cohen d=0.26 and within-group: Cohen d=-0.23 vs 0.13). No ER and self-compassion domains were mediators of the effect of MEMI on SAD symptoms (P=.07-<.99), generalized anxiety symptoms (P=.16-.98), depression severity (P=.20-.94), repetitive negative thinking (P=.12-.96), and trait mindfulness (P=.18-.99) from pretrial to postintervention time points. Similar nonsignificant mediation effects emerged for all of these clinical outcomes from pretrial to 1-month follow-up time points (P=.11-.98).
CONCLUSIONS: Brief, fully self-guided, mobile MEMIs efficaciously increased specific self-compassion domains and decreased ER difficulties associated with goal pursuit and clarity of emotions from pretrial to midintervention time points. Higher-intensity MEMIs may be required to pinpoint the specific change mechanisms in ER and self-compassion domains of SAD.
TRIAL REGISTRATION: Open Science Framework (OSF) Registries; osf.io/m3kxz https://osf.io/m3kxz.

Keywords

References

  1. Stress Health. 2020 Feb;36(1):88-96 [PMID: 31874122]
  2. Am J Psychiatry. 1992 Jul;149(7):936-43 [PMID: 1609875]
  3. Mindfulness (N Y). 2023;14(9):2155-2171 [PMID: 37795338]
  4. J Pers Assess. 1996 Dec;67(3):588-97 [PMID: 8991972]
  5. Compr Psychiatry. 2010 Nov-Dec;51(6):630-40 [PMID: 20965310]
  6. Behav Res Ther. 2006 Aug;44(8):1177-85 [PMID: 16257387]
  7. Psychiatry Clin Neurosci. 2013 Apr;67(3):160-6 [PMID: 23581867]
  8. Br J Psychiatry. 2000 Apr;176:379-86 [PMID: 10827888]
  9. J Consult Clin Psychol. 2013 Apr;81(2):318-35 [PMID: 22663900]
  10. Scand J Psychol. 2023 Aug;64(4):390-400 [PMID: 36707979]
  11. Psychol Methods. 2019 Feb;24(1):1-19 [PMID: 30265048]
  12. J Altern Complement Med. 2016 May;22(5):363-74 [PMID: 27070853]
  13. Cogn Behav Ther. 2016 Apr;45(3):236-57 [PMID: 27046641]
  14. Mindfulness (N Y). 2020;11(8):1914-1934 [PMID: 32421083]
  15. J Psychiatr Res. 2014 Nov;58:175-80 [PMID: 25171941]
  16. Anxiety Stress Coping. 2012;25(5):543-58 [PMID: 21895450]
  17. Clin Psychol Rev. 2010 Mar;30(2):217-37 [PMID: 20015584]
  18. Clin Psychol Rev. 2012 Aug;32(6):545-52 [PMID: 22796446]
  19. J Couns Psychol. 2022 Mar;69(2):157-171 [PMID: 34264696]
  20. Psychol Methods. 2018 Jun;23(2):244-261 [PMID: 29172614]
  21. J Affect Disord. 2020 Feb 15;263:413-419 [PMID: 31969272]
  22. Curr Psychiatry Rep. 2019 Mar 2;21(3):17 [PMID: 30826879]
  23. J Consult Clin Psychol. 2015 Feb;83(1):157-68 [PMID: 25181028]
  24. Psychol Psychother. 2023 Sep;96(3):762-777 [PMID: 37070732]
  25. Behav Res Ther. 2020 Dec;135:103746 [PMID: 33011486]
  26. J Consult Clin Psychol. 2023 May;91(5):285-300 [PMID: 36634023]
  27. PLoS One. 2017 Dec 6;12(12):e0187727 [PMID: 29211754]
  28. J Anxiety Disord. 2014 Jan;28(1):25-30 [PMID: 24334213]
  29. Psychother Res. 2023 Nov;33(8):991-1003 [PMID: 36226476]
  30. Behav Cogn Psychother. 2023 Sep;51(5):443-458 [PMID: 37288653]
  31. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86 [PMID: 11132119]
  32. Dev Psychopathol. 2023 Oct;35(4):2061-2072 [PMID: 35959684]
  33. Psychol Med. 2021 Mar 26;:1-9 [PMID: 33766151]
  34. Int J Psychophysiol. 2022 Sep;179:30-42 [PMID: 35753561]
  35. J Consult Clin Psychol. 2018 Jul;86(7):569-583 [PMID: 29939051]
  36. PLoS One. 2017 Sep 25;12(9):e0184823 [PMID: 28945776]
  37. Psychol Methods. 2007 Mar;12(1):23-44 [PMID: 17402810]
  38. BMC Med Res Methodol. 2013 Dec 06;13:150 [PMID: 24314204]
  39. Assessment. 2021 Mar;28(2):485-502 [PMID: 31538795]
  40. Psychother Res. 2024 Feb;34(2):182-194 [PMID: 36803684]
  41. Curr Opin Psychol. 2019 Aug;28:120-125 [PMID: 30639835]
  42. Asian J Psychiatr. 2021 Jan;55:102526 [PMID: 33360708]
  43. West J Emerg Med. 2017 Oct;18(6):1075-1078 [PMID: 29085540]
  44. Health Psychol Rev. 2023 Aug 30;:1-27 [PMID: 37578065]
  45. J Affect Disord. 2018 Feb;227:432-442 [PMID: 29154165]
  46. Eur Arch Psychiatry Clin Neurosci. 2021 Oct;271(7):1217-1229 [PMID: 34245349]
  47. Appl Psychol Health Well Being. 2018 Jul;10(2):215-235 [PMID: 29673093]
  48. J Anxiety Disord. 2024 Mar 24;104:102858 [PMID: 38657408]
  49. Psychol Med. 2003 May;33(4):623-35 [PMID: 12785464]
  50. Psychophysiology. 2002 May;39(3):281-91 [PMID: 12212647]
  51. Front Psychol. 2017 Mar 06;8:220 [PMID: 28321194]
  52. Annu Rev Psychol. 2017 Jan 3;68:491-516 [PMID: 27687118]
  53. Health Psychol. 2008 Mar;27(2S):S101-8 [PMID: 18377151]
  54. J Abnorm Psychol. 2019 May;128(4):295-304 [PMID: 31045412]
  55. Front Psychol. 2018 Oct 31;9:2090 [PMID: 30429816]
  56. Emotion. 2021 Jun;21(4):842-855 [PMID: 32191093]
  57. Int J Environ Res Public Health. 2021 Dec 23;19(1): [PMID: 35010414]
  58. Curr Psychiatry Rep. 2022 Dec;24(12):871-880 [PMID: 36401677]
  59. Curr Psychiatry Rep. 2015 Jan;17(1):531 [PMID: 25413637]
  60. J Ment Health. 2021 Jun;30(3):284-291 [PMID: 31661997]
  61. Behav Modif. 2022 Jan;46(1):36-62 [PMID: 32752883]
  62. Psychother Res. 2009 Jul;19(4-5):418-28 [PMID: 19034715]
  63. PLoS One. 2018 Jun 29;13(6):e0199750 [PMID: 29958268]
  64. Behav Ther. 2020 May;51(3):413-423 [PMID: 32402257]
  65. J Am Coll Health. 2013;61(6):348-60 [PMID: 23930749]
  66. Assessment. 2019 Sep;26(6):1084-1104 [PMID: 28355881]
  67. Clin Rheumatol. 2011 Aug;30(8):1045-54 [PMID: 21347605]
  68. Psychol Assess. 2016 Aug;28(8):1009-14 [PMID: 26460893]
  69. Eur Psychiatry. 2023 Jan 16;66(1):e12 [PMID: 36645098]
  70. Behav Res Ther. 2014 Jul;58:43-51 [PMID: 24929927]
  71. Depress Anxiety. 2016 Sep;33(9):829-39 [PMID: 27062682]
  72. J Psychosom Res. 2018 Nov;114:62-71 [PMID: 30314581]
  73. Cogn Behav Ther. 2023 Jan;52(1):18-37 [PMID: 36254613]
  74. Br J Clin Psychol. 2014 Mar;53(1):6-41 [PMID: 24588760]
  75. J Affect Disord. 2018 Feb;227:824-833 [PMID: 29254067]
  76. Front Psychol. 2021 Nov 11;12:720965 [PMID: 34858260]
  77. Mindfulness (N Y). 2022;13(11):2691-2704 [PMID: 36160038]
  78. Perspect Psychiatr Care. 2008 Oct;44(4):241-7 [PMID: 18826462]
  79. Drug Alcohol Depend. 2016 Jun 01;163 Suppl 1:S13-8 [PMID: 27306725]
  80. Am Psychol. 1991 Aug;46(8):819-34 [PMID: 1928936]
  81. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jan;5(1):119-129 [PMID: 31547972]
  82. J Med Internet Res. 2011 Dec 31;13(4):e126 [PMID: 22209829]
  83. Behav Res Ther. 2017 Oct;97:1-13 [PMID: 28654771]
  84. J Affect Disord. 2021 Dec 1;295:1360-1370 [PMID: 34706449]
  85. Psychol Methods. 2006 Jun;11(2):142-63 [PMID: 16784335]
  86. Health Psychol. 2019 Aug;38(8):759-768 [PMID: 31120272]
  87. Assessment. 2008 Sep;15(3):329-42 [PMID: 18310597]
  88. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3488-3493 [PMID: 30808743]
  89. Obes Res Clin Pract. 2017 Sep - Oct;11(5 Suppl 1):90-111 [PMID: 27658995]
  90. Appl Psychol Health Well Being. 2022 Nov;14(4):1151-1171 [PMID: 34962055]
  91. Clin Psychol Rev. 2017 Feb;51:48-59 [PMID: 27835764]
  92. Behav Res Ther. 2021 Dec;147:103984 [PMID: 34740099]
  93. Psychol Methods. 2021 Aug;26(4):466-485 [PMID: 33507765]

Grants

  1. R01 MH115128/NIMH NIH HHS

MeSH Term

Humans
Mindfulness
Phobia, Social
Self-Compassion
Emotional Regulation
Emotions